Drug Design Development and Therapy
Emodin in Skeletal Muscle Ischemia-Reperfusion: Model Validity and Analytical Concerns [Letter]
By Huayi Gao, Ruiyi Zhang and Mengzhou Xue.
Abstract
Huayi Gao,1,2 Ruiyi Zhang,1 Mengzhou Xue11Department of Cerebrovascular Diseases, The Second Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, People’s Republic of China; 2Department of Rehabilitation Medicine, The Second Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, People’s Republic of ChinaCorrespondence: Mengzhou Xue, Department of Cerebrovascular Diseases, The Second Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, People’s Republic of China, Email xmengzhou@126.com
Keywords
- Cardiac Ischemia and Reperfusion
- emodin
- model validity
- analytical method validation
- muscle damage
- Open access
Source
Published in Drug Design Development and Therapy. The abstract is shown as published and remains the work of its authors; read the full article at the source.
Prognia lists this article for reference and education. It is not medical advice. Always read the original and follow current guidelines and local protocols before acting on it.
